Medicaid Adds Pfizer BioNTech COVID-19 Vaccine to Formulary

Published on
December 16, 2020

The Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the use of the Pfizer-BioNTech COVID-19 Vaccine on Dec. 11, 2020,

HHSC will add the vaccine to the formulary for the Medicaid, Children’s Health Insurance Program (CHIP) and Healthy Texas Women (HTW) programs as a payable pharmacy benefit beginning Dec. 28. VDP will backdate the effective date of formulary coverage to Dec. 11 to align with medical benefit requirements, meaning pharmacy claims with dates of service starting Dec. 11 are allowed beginning Dec. 28.

Manufacturer

Drug Name

NDC

Pfizer-BioNTech

COVID-19 Vaccine EUA

59267-1000-01